PD-L1hi retinal pigment epithelium (RPE) cells elicited by inflammatory cytokines induce regulatory activity in uveitogenic T cells

Journal of Leukocyte Biology

Volumn 88, Issue 6, 2010, Pages 1241-1249

  Ke, Yan ^a   Sun, Deming ^b   Jiang, Guomin ^a   Kaplan, Henry J ^a   Shao, Hui ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Autoimmunity; Inflammation; Tissue cells

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; PD L1; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; EYE INFLAMMATION; FEMALE; MOUSE; NONHUMAN; PATHOGENICITY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; UVEITIS;

ANIMALS; ANTIGENS, CD80; CELLS, CULTURED; CYTOKINES; EYE PROTEINS; FEMALE; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; MEMBRANE GLYCOPROTEINS; MICE; PEPTIDES; RETINAL PIGMENT EPITHELIUM; RETINOL-BINDING PROTEINS; T-LYMPHOCYTES; UVEITIS;

ERAGROSTIS TEF; MUS;

EID: 78649753884     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0610332     Document Type: Article

References (54)

1. Luger, D., Silver, P. B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E. P., Sgambellone, N. M., Chan, C. C., Caspi, R. R. (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205, 799-810. (Pubitemid 351549879)
2. Peng, Y., Han, G., Shao, H., Wang, Y., Kaplan, H. J., Sun, D. (2007) Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 48, 4153-4161.
3. Amadi-Obi, A., Yu, C. R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I., Lee, Y. S., Egwuagu, C. E. (2007) TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13, 711-718.
4. Cox, C. A., Shi, G., Yin, H., Vistica, B. P., Wawrousek, E. F., Chan, C. C., Gery, I. (2008) Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J. Immunol. 180, 7414-7422.
5. Ishida, K., Panjwani, N., Cao, Z., Streilein, J. W. (2003) Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms. Ocul. Immunol. Inflamm. 11, 91-105.
6. Ke, Y., Jiang, G., Sun, D., Kaplan, H. J., Shao, H. (2009) Retinal astrocytes respond to IL-17 differently than retinal pigment epithelial cells. J. Leukoc. Biol. 86, 1377-1384.
7. Sugita, S., Futagami, Y., Smith, S. B., Naggar, H., Mochizuki, M. (2006) Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor β. Exp. Eye Res. 83, 1459-1471.
8. Sun, D., Enzmann, V., Lei, S., Sun, S. L., Kaplan, H. J., Shao, H. (2003) Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J. Neuroimmunol. 144, 1-8.
9. Shakib, M., Zinn, K. M. (1973) Fine structure and function of ocular tissues. The choroid, Bruch's membrane, and the retinal pigment epithelium. Int. Ophthalmol. Clin. 13, 189-204.
10. Futagami, Y., Sugita, S., Vega, J., Ishida, K., Takase, H., Maruyama, K., Aburatani, H., Mochizuki, M. (2007) Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells. J. Immunol. 178, 6994-7005.
11. Sugita, S. (2009) Role of ocular pigment epithelial cells in immune privilege. Arch. Immunol. Ther. Exp. (Warsz) 57, 263-268.
12. Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R., Ferguson, T. A. (1996) CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5, 7-16.
13. Willermain, F., Caspers-Velu, L., Nowak, B., Stordeur, P., Mosselmans, R., Salmon, I., Velu, T., Bruyns, C. (2002) Retinal pigment epithelial cells phagocytosis of T lymphocytes: possible implication in the immune privilege of the eye. Br. J. Ophthalmol. 86, 1417-1421.
14. Keir, M. E., Butte, M. J., Freeman, G. J., Sharpe, A. H. (2008) PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677-704.
15. Okazaki, T., Honjo, T. (2007) PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19, 813-824.
16. + T-cell-mediated injury of vascular endothelial cells. Eur. J. Immunol. 40, 733-743.
17. Tiegs, G., Lohse, A. W. (2010) Immune tolerance: what is unique about the liver. J. Autoimmun. 34, 1-6.
18. + T-cell activity. Gastroenterology 135, 1228-1237.
19. Lucas, J. A., Menke, J., Rabacal, W. A., Schoen, F. J., Sharpe, A. H., Kelley, V. R. (2008) Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice. J. Immunol. 181, 2513-2521.
20. Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., Sharpe, A. H. (2006) Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203, 883-895.
21. Fife, B. T., Guleria, I., Gubbels, B. M., Eagar, T. N., Tang, Q., Bour-Jordan, H., Yagita, H., Azuma, M., Sayegh, M. H., Bluestone, J. A. (2006) Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203, 2737-2747.
22. Menke, J., Lucas, J. A., Zeller, G. C., Keir, M. E., Huang, X. R., Tsuboi, N., Mayadas, T. N., Lan, H. Y., Sharpe, A. H., Kelley, V. R. (2007) Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles. J. Immunol. 179, 7466-7477.
23. Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., Azuma, M., Yagita, H., Sayegh, M. H., Khoury, S. J. (2003) Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198, 71-78.
24. Mataki, N., Kikuchi, K., Kawai, T., Higashiyama, M., Okada, Y., Kurihara, C., Hokari, R., Kawaguchi, A., Nagao, S., Kondo, T., Itoh, K., Miyakawa, H., Miura, S. (2007) Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases. Am. J. Gastroenterol. 102, 302-312.
25. + T cells in pregnancy. J. Reprod. Immunol. 80, 12-21.
26. Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., Azuma, M. (2006) B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177, 5928-5935.
27. Wang, L., Han, R., Hancock, W. W. (2007) Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Eur. J. Immunol. 37, 2983-2990.
28. Yang, J., Popoola, J., Khandwala, S., Vadivel, N., Vanguri, V., Yuan, X., Dada, S., Guleria, I., Tian, C., Ansari, M. J., Shin, T., Yagita, H., Azuma, M., Sayegh, M. H., Chandraker, A. (2008) Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation 117, 660-669.
29. Morita, M., Fujino, M., Jiang, G., Kitazawa, Y., Xie, L., Azuma, M., Yagita, H., Nagao, S., Sugioka, A., Kurosawa, Y., Takahara, S., Fung, J., Qian, S., Lu, L., Li, X. K. (2010) PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am. J. Transplant. 10, 40-46.
30. Hattori, T., Kezuka, T., Usui, Y., Okunuki, Y., Takeuchi, M., Maruyama, K., Haneda, M., Shirato, S., Goto, H. (2009) Human iris pigment epithelial cells suppress T-cell activation via direct cell contact. Exp. Eye Res. 89, 358-364.
31. Sugita, S., Usui, Y., Horie, S., Futagami, Y., Aburatani, H., Okazaki, T., Honjo, T., Takeuchi, M., Mochizuki, M. (2009) T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Invest. Ophthalmol. Vis. Sci. 50, 2862-2870.
32. Jiang, G., Ke, Y., Sun, D., Han, G., Kaplan, H. J., Shao, H. (2008) Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice. Invest. Ophthalmol. Vis. Sci. 49, 282-289.
33. Shao, H., Liao, T., Ke, Y., Shi, H., Kaplan, H. J., Sun, D. (2006) Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp. Eye Res. 82, 323-331. (Pubitemid 43122119)
34. Shao, H., Fu, Y., Song, L., Sun, S., Kaplan, H. J., Sun, D. (2003) Lymphotoxin β receptor-Ig fusion protein treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats. Eur. J. Immunol. 33, 1736-1743.
35. Shao, H., Huang, Z., Sun, S. L., Kaplan, H. J., Sun, D. (2004) Myelin/oligodendrocyte glycoprotein-specific T-cells induce severe optic neuritis in the C57BL/6 mouse. Invest. Ophthalmol. Vis. Sci. 45, 4060-4065. (Pubitemid 39411161)
36. + uveitogenic T cells specific for interphotoreceptor retinal-binding protein 1177-1191. J. Immunol. 173, 2849-2854.
37. Caspi, R. R., Roberge, F. G., Nussenblatt, R. B. (1987) Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science 237, 1029-1032.
38. Helbig, H., Gurley, R. C., Palestine, A. G., Nussenblatt, R. B., Caspi, R. R. (1990) Dual effect of ciliary body cells on T lymphocyte proliferation. Eur. J. Immunol. 20, 2457-2463.
39. Sun, D., Coleclough, C., Whitaker, J. N. (1997) Nonactivated astrocytes downregulate T cell receptor expression and reduce antigen-specific proliferation and cytokine production of myelin basic protein (MBP)-reactive T cells. J. Neuroimmunol. 78, 69-78.
40. +) regulatory T cells suppress activation of intraocular effector T cells. Clin. Immunol. 136, 83-95.
41. Kaestel, C. G., Jorgensen, A., Nielsen, M., Eriksen, K. W., Odum, N., Holst, N. M., Ropke, C. (2002) Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp. Eye Res. 74, 627-637.
42. Sugita, S., Streilein, J. W. (2003) Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 198, 161-171.
43. Zamiri, P., Zhang, Q., Streilein, J. W. (2004) Vulnerability of allogeneic retinal pigment epithelium to immune T-cell-mediated damage in vivo and in vitro. Invest. Ophthalmol. Vis. Sci. 45, 177-184.
44. Sugita, S., Horie, S., Nakamura, O., Maruyama, K., Takase, H., Usui, Y., Takeuchi, M., Ishidoh, K., Koike, M., Uchiyama, Y., Peters, C., Yamamoto, Y., Mochizuki, M. (2009) Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2α during inflammatory conditions. J. Immunol. 183, 5013-5022.
45. Sugita, S., Horie, S., Nakamura, O., Futagami, Y., Takase, H., Keino, H., Aburatani, H., Katunuma, N., Ishidoh, K., Yamamoto, Y., Mochizuki, M. (2008) Retinal pigment epithelium-derived CTLA-2α induces TGFβ-producing T regulatory cells. J. Immunol. 181, 7525-7536.
46. Sugita, S., Usui, Y., Horie, S., Futagami, Y., Yamada, Y., Ma, J., Kezuka, T., Hamada, H., Usui, T., Mochizuki, M., Yamagami, S. (2009) Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism. Invest. Ophthalmol. Vis. Sci. 50, 263-272.
47. Schreiner, B., Bailey, S. L., Shin, T., Chen, L., Miller, S. D. (2008) PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur. J. Immunol. 38, 2706-2717.
48. Jiang, G., Ke, Y., Sun, D., Wang, Y., Kaplan, H. J., Shao, H. (2009) Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Invest. Ophthalmol. Vis. Sci. 50, 4769-4776.
49. Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., Sharpe, A. H. (2009) PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015-3029.
50. Ke, Y., Liu, K., Huang, G. Q., Cui, Y., Kaplan, H. J., Shao, H., Sun, D. (2009) Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J. Immunol. 182, 3183-3190.
51. Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., Achong, M. K. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311-320.
52. Flaishon, L., Topilski, I., Shoseyov, D., Hershkoviz, R., Fireman, E., Levo, Y., Marmor, S., Shachar, I. (2002) Cutting edge: anti-inflammatory properties of low levels of IFN-γ. J. Immunol. 168, 3707-3711.
53. Barrett, S. P., Gleeson, P. A., de Silva, H., Toh, B. H., van, Driel, I. (1996) Interferon-γ is required during the initiation of an organ-specific autoimmune disease. Eur. J. Immunol. 26, 1652-1655.
54. Christen, U., Wolfe, T., Mohrle, U., Hughes, A. C., Rodrigo, E., Green, E. A., Flavell, R. A., von Herrath, M. G. (2001) A dual role for TNF-α in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166, 7023-7032.